158948-96-0
Paclitaxel impurity 19/Taxol E/(αR,βS)-α-Hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetr
CAS: 158948-96-0
Molecular Formula: C45H55NO14
158948-96-0 - Names and Identifiers
158948-96-0 - Physico-chemical Properties
| Molecular Formula | C45H55NO14 |
| Molar Mass | 833.93 |
| Density | 1.35±0.1 g/cm3(Predicted) |
| Boling Point | 922.6±65.0 °C(Predicted) |
| pKa | 11.91±0.20(Predicted) |
158948-96-0 - Reference Information
| use | paclitaxel EP impurity is paclitaxel impurity; antineoplastic drugs. It is used to study the structural and functional transformation of microtubules into tubulin. Paclitaxel is now used to treat lung cancer, ovarian cancer, breast cancer, head and neck cancer, and advanced Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. |
Last Update：2024-04-09 20:49:11
